Covering: This market research report includes a detailed segmentation of the immunodiagnostic market in China by technology type (CLIA, ELISA, FIA, MIA, LFIA, and RIA), by product (reagent and instrument), by analyzer type (standalone analyzer and integrated analyzer), and by mode of operation (automated systems, semi-automated systems, and manual systems). The key vendors in this report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare Diagnostics, Beckman Coulter, and Sysmex Medical Electronics.
Market outlook of the immunodiagnostic market in the China
Technavios market research analyst estimates the immunodiagnostics market in China to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare reforms, growing preference for local manufacture of diagnostic devices, and rapidly increasing competition are some of the significant factors that augment growth in this market during the forecast period.
The rising prevalence of infectious and chronic diseases in this region is the primary growth driver for this market. In China, urbanization has led to an increase in the prevalence of chronic diseases like cancer, diabetes, cardiovascular diseases, and tuberculosis. This high prevalence of chronic diseases is envisaged to bolster the need for immunodiagnostic tests, which in turn would result in market growth during the forecast period.
Competitive landscape and key vendors The immunodiagnostic market in the China is consolidated due to the presence of numerous small, medium, and large vendors. The vendors in this market compete on the basis of product differentiation, application differentiation, portfolio, and pricing to gain maximum market traction during the forecast period.
The top vendors in the market are - Roche Diagnostics Abbott Diagnostics Siemens Healthcare Diagnostics Beckman Coulter Sysmex Medical Electronics (Shangai)
Other prominent vendors in the market include AccuBio Tech,Alere,Becton Dickinson,Beijing Kewei Clinical Diagnostics Reagents, Beijing Leadman Biochemistry,Bio-RadBioscience Diagnostic Technology,Biosino Biotechnology & Science, DIAsource, DiaSys Diagnostic Systems, Fosun Pharma, Getein Biotechnology, Hitachi, Immunodiagnostic System Holdings, Luminex, NewScen Coast Bio-Pharmaceutical, Ortho Clinical Diagnostics, Shanghai Kehua Bio-engineering, Sichuan Maccura Biotechnology, Tecan, and Thermofisher Scientific.
Technological segmentation of the immunodiagnostic market in China ELISA CLIA RIA FIA MIA LFIA
According to this global market research report, the chemiluminescence (CLIA) assay segment is anticipated to be the largest market segment during the forecast period. The ability of this assay to perform clinical applications at a rapid pace is a major factor that augments its adoption during the forecast period. Moreover, this assays ability to make sample detection sensitive and easy is envisaged to result in its profound market share of more than 66% by 2020.
Product-type segmentation and analysis of the immunodiagnostic market in China Reagent Instrument
Technavio market research analysts estimate the reagents segment to account for a market share of approximately 82% during the forecast period. The ability of reagents to diagnose minute quantities of biological agents like hormones, viruses, vitamins, or immunogenic substances in blood samples is anticipated to result in its high adoption during the predicted period.
Key questions answered in the report include What will the market size and the growth rate be in 2020 What are the key factors driving the immunodiagnostic market in the China What are the key market trends impacting the growth of the immunodiagnostic market in the China What are the challenges to market growth Who are the key vendors in this market space What are the market opportunities and threats faced by the vendors in the immunodiagnostic market in the China What are the key outcomes of the five forces analysis of the immunodiagnostic market in the China
Related reports Global Bone and Mineral Diagnostic Testing Market 2015-2019 USA In-Vitro Diagnostics Vitamin D Testing Market 2015-2019 Global Immunodiagnostics Market 2015-2019 Clinical Diagnostics Market in APAC - Market Analysis 2015-2019
Technavio Announces the Publication of its Research Report Immunodiagnostics Market in China 2016-2020
Technavio recognizes the following companies as the key players in the Immunodiagnostics Market in China: Abbott Diagnostics, Beckman Coulter Diagnostics, Roche Diagnostics and Siemens Healthcare Diagnostics
Other Prominent Vendors in the market are: BioSino Bio-technology & Science, DiaSorin, Immunodiagnostic System Holdings (IDS), Mindray Medical International, Shanghai Kehua Bio-engineering and Sichuan Maccura Biotechnology
Commenting on the report, an analyst from Technavios team said: Theaccelerated rate of diseases and growing aging population makes the immunodiagnostics market in China attractive for foreign players. Locally manufactured products in China are often of poor quality due to lack of support technologies and funding. Multinational companies are associated with a certain brand value. They have tapped into the opportunity in China by associating or acquiring local vendors.
According to the report, CLIAs are advantageous compared to traditional immunoassays as they can analyze and detect analytes from hundreds of samples each hour. They also require less labor and consume fewer reagents. These benefits allow the merging of these tests with automated analyzers, thereby rendering a potential high-throughput analysis of samples in hospitals settings. As the market for automated and semi-automated systems to analyze immunoassays is growing, the adoption of CLIA-based assays is expected to accelerate.
Further, the report states that even though the number of patent filings and approvals are increasing in China, the fear of duplication of medical devices is a major threat and challenge in the market.